Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

The European Union has become a leading COVID-19 vaccine exporter 

By Brian Buntz | October 18, 2021

EU flagThe European Union is now one of the largest exporters of COVID-19 vaccines globally, having provided 150 nations with more than 1 billion vaccine doses.

The U.S. has exported fewer than 200 million vaccine doses to date but has pledged to donate more than 1 billion.

China has pledged to donate 2 billion doses by the end of the year. As of September 23, the Chinese foreign ministry stated that China had exported 1.2 billion doses to more than 100 countries.

The EU announced in September that it would provide an additional 200 million doses to low-income countries in Africa and elsewhere.

“We know that other countries also have to step up,” EU Commission President Ursala von der Leyen told the AP. “That’s the only way to beat the pandemic.”

To date, 47.6% of the world’s population has received at least one dose of vaccine, according to Our World in Data. But most of those doses have gone to middle- and high-income nations. Less than 3.0% of the people in low-income countries have received at least one dose.

In related news, India announced in late September that it would also resume exporting vaccines to the COVID-19 Vaccines Global Access (commonly known as “COVAX”).

The country is one of the world’s top vaccine exporters, but halted vaccine shipments to other countries when dealing with a Delta-variant induced spike in infections.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

institut pasteur dakar IPD African Union vaccine investment
African Union vaccine initiative receives $45M
Sen-Jam Pharma, KVK-Tech partnering for manufacturing and formulation for anti-inflammatory injectables
This image shows the Moderna logo.
Moderna resizes its manufacturing footprint for a post-pandemic era
This is the logo of Pfizer.
Pfizer to close Durham and Morrisville, North Carolina facilities amid major restructuring effort
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE